Sesen Bio Further Enhances Team with Key Hires
Sesen Bio, a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, announced the appointments of Minori Rosales, M.D., Ph.D. as Chief Development Officer as of January 24, 2022 and Stephanie Vigue as Director of Finance as of January 17, 2022.
Esteemed Psychologist Dr. Risa Weisberg Joins BehaVR as Chief Clinical Officer
Licensed clinical psychologist, Dr. Risa Weisberg, PhD., has been appointed Chief Clinical Officer at BehaVR (@BehaVR_al), an innovator in virtual reality digital wellness and digital therapeutics experiences. Dr. Weisberg is a renowned expert in cognitive behavioral therapy, a Professor of Psychiatry at Boston University School of Medicine, and an Adjunct Professor of Family Medicine at Brown University.
Spruce Biosciences Appoints Javier Szwarcberg, M.D., MPH as Chief Executive Officer
Spruce Biosciences, Inc. (@Spruce_Bio), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, announced that Dr. Javier Szwarcberg, M.D., MPH, has been appointed Chief Executive Officer and as a member of the board of directors. Samir Gharib, MBA, has been concurrently promoted to President and will continue in his role as Chief Financial Officer.
Rob Cohen Named CEO at Bamboo Health
Bamboo Health™ (@BambooHLTH), formerly Appriss Health and PatientPing, a healthcare technology solutions company focused on fostering care collaboration and providing information and actionable insights across the entire continuum of care, announced that Rob Cohen, president and general manager of Bamboo Health, is assuming the role of CEO effective December 16, 2021.
Wellvana Welcomes Kyle Wailes as New CEO
National value-based care company Wellvana (@WellvanaHealth) announced that its Board of Directors has appointed Kyle Wailes as its new Chief Executive Officer. Mr. Wailes will be transitioning from his role as Chief Financial Officer for SmileDirectClub Inc. through March, 2022.
MediSYS Announces Promotion of Mark Lewis to VP of Sales
MediSYS (@MediSYSInc_MD), an Alabama-headquartered provider of medical practice software and services, announced the promotion of Mark Lewis to Vice President of Sales. Mark will be responsible for guiding and developing sales efforts for the company.
Discovery Behavioral Health Announces Appointment of Andrea Piazza as First Director of Virtual Programming
Discovery Behavioral Health, Inc. (@DiscovBeHealth), an expanding nationwide network of evidence-based mental health, substance use and eating disorder treatment centers, has announced the appointment of Andrea Piazza as Director of Virtual Programming, reporting to Alexa Baghdassarian, LMFT, VP of Operations.
Matrix Medical Network Appoints Tom Catchings as Chief Information Officer
Matrix Medical Network® (@MatrixMedNtwk) announced the appointment of Tom Catchings as Chief Information Officer. For more than 20 years, Matrix has met individuals where they live and work to assess health and safety, identify and close care gaps, and offer life-changing services that empower them to better manage their own health.
Verdi Oncology Announces New Hires to Support Community Oncology
Verdi Oncology announced that it has enhanced its leadership team over the latter half of the year with the additions of Bill Herman (CEO), Audrey Soskin (CFO), and Brian Battey (SVP-Strategic Growth). The executives will drive the critical support for sustainable growth of Verdi’s uniquely focused network of small, community-based oncology practices.
Andy Corts Appointed OneOncology Chief Technology Officer
OneOncology (@OneOncology), the national platform for independent community oncology practices, announced that health technology industry veteran, Andy Corts, has joined the company as its Chief Technology Officer. Corts was most recently senior vice president of Research and Analytics for SignalPath, a Verily | Alphabet company, where he led their analytics and research strategy.